Immuno-Biological Laboratories: Notice of patent acquisition relating to “anti-HIV antibodies and their manufacturing methods”
Immuno-Biological Laboratories: Announcements of individual stocks regarding the manufacturing and sales notification of in vitro diagnostic pharmaceuticals.
Immuno-Biological Laboratories: Announcements of individual stocks: Exclusive licensing agreement signed for the SFTS virus antibody gene against severe fever with thrombocytopenia syndrome.
Immuno-Biological Laboratories: Announcements of individual stocks regarding the status of joining the Public Interest Incorporated Foundation Financial Accounting Standards Board and thoughts on joining.
Immuno-Biological Laboratories: Announcements of individual stocks related to compliance with listing maintenance standards.
IMMUNO-BIOLOGICAL LABORATORIES: Explanation of business plans and growth potential
IMMUNO-BIOLOGICAL LABORATORIES: Notice regarding the recording of book value devaluation of fixed assets (return of operating expenses), non-operating income, extraordinary losses, and corporate tax adjustments
Immuno-Biological Laboratories: Notice Concerning Patent Acquisition
Immuno-Biological Laboratories: Notice regarding the start of manufacture and sale of the research reagent “Human Uromodulin ELISA Kit-IBL”
Immuno-Biological Laboratories: Notice regarding OEM provision of “human collagen I” produced with genetically modified silkworms
Institute for Immunobiology: Notice regarding personnel changes
Institute for Immunobiology: Notice regarding obtaining approval for the manufacture and sale of in vitro diagnostic pharmaceuticals
Immuno-Biological Laboratories: Notice Concerning the Recording of Non-Operating Income and Extraordinary Losses
Immuno-Biological Laboratories: Notice Concerning the Recording of Non-Operating Income and Extraordinary Losses
Immuno-Biological Laboratories: Notice Concerning the Recording of Non-Operating Income and Extraordinary Losses
Immuno-Biological Laboratories: Notice regarding the status of enrollment in the Financial Accounting Standards Organization Foundation and the way of thinking about enrolment
Immuno-Biological Laboratories: Plans for compliance with listing maintenance standards
Immuno-Biological Laboratories: Explanation of business plans and growth potential
Immuno-Biological Laboratories: Notice Concerning the Recording of Non-Operating Profit
Immuno-Biological Laboratories: Notice Concerning Decrease in Amount of Capital and Capital Reserve and Disposal of Surplus Funds
No Data
No Data